Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Procaps Group SA PROC

Healthcare
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PROC)

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Business Wire 8 days ago

Procaps Group Delays Filing of Annual Report on Form 20-F

Business Wire May 14, 2024

Procaps Group Delays Filing of Annual Report on Form 20-F

Business Wire May 1, 2024

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Business Wire March 4, 2024

Procaps Issues Shareholder Letter from New CEO

Business Wire February 5, 2024

Procaps Group - Notice to Shareholders

Business Wire January 16, 2024

Procaps Group Reports Third Quarter 2023 Results

Business Wire December 26, 2023

Statement from the Board of Directors of Procaps Group

Business Wire December 21, 2023

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Business Wire November 29, 2023
View More News ››

Opinion & Analysis (NDAQ:PROC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PROC)

Be the first to post on this bullboard.

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »